Ultraviolet radiation exposure, vitamin D, and cancer

Photochemistry and Photobiology

Volumn 81, Issue 6, 2005, Pages 1261-1266

  Berwick, Marianne ^a   Kesler, Denece ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D;

EPIDEMIOLOGY; HUMAN; PHYSIOLOGY; REPRODUCIBILITY; REVIEW; SKIN TUMOR; ULTRAVIOLET RADIATION;

EPIDEMIOLOGIC RESEARCH DESIGN; HUMANS; REPRODUCIBILITY OF RESULTS; SKIN NEOPLASMS; ULTRAVIOLET RAYS; VITAMIN D;

EID: 29844438188     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1562/2005-02-18-IR-445     Document Type: Review

References (65)

1. Garland, C., R. B. Shekelle, E. Barrett-Connor, M. H. Criqui, A. H. Rossof and O. Paul. (1985) Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 1, 307-309.
2. Hanchette, C. L. and G.G. Schwartz. (1992) Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 70, 2861-2869.
3. Takahashi, K., G. Pan, Y. Feng, M. Ohtaki, S. Watanabe and N. Yamaguchi. (1999) Regional correlation between estimated UVB levels and skin cancer mortality in Japan. J. Epidemiol. 9, S123-S128.
4. Berwick M., B. K. Armstrong L. Ben-Porat, J. Fine, A. Kricker, C. Eberle and R. L. Barnhill (2005) Sun exposure and melanoma mortality. J. Natl. Cancer Inst. 97 (3), 195-199.
5. Hughes, A. M., B. K. Armstrong, C. M. Vajdic, J. Turner, A. E. Grulich, L. Fritschi, S. Milliken, J. Kaldor, G. Benke and A. Kricker. (2004) Sun exposure may protect against non-Hodgkin lymphoma: a case-control study. Int. J. Cancer 112, 865-871.
6. Smedby K. E., H. Hjalgrim, M. Melbye, A. Torrang, K. Rostgaard, L. Munksgaard, J. Adami, M. Hansen, A. Porwit-MacDonald, B. A. Jensen, G. Roos, B. B. Pedersen, C. Sundstrom, B. Glimelius and H. O. Adami. (2005) Ultraviolet radiation exposure and risk of malignant lymphomas. J. Natl. Cancer Inst. 97 (3), 199-209.
7. Reichrath, J., M. Rech, M. Moeini, V. Meineke, W. Tilgen and M. Seifert. (2005) Modulation of Vitamin D-induced growth inhibition in melanoma cell lines: implications for an important function of vitamin D receptor (VDR) and 1,25-dihydroxyvitamin D-24-hydroxylase (24-OHase) expression, histonedeacetylation, and calpain activity. Exp. Dermatol. 14, 154.
8. Working Group of the Australian and New Zealand Bone and Mineral Soceity, Endocrine Society of Australia and Osteoporosis Australia (2005) Vitamin D and adult bone health in Australia and New Zealand: a position statement. Med. J. Aust. 182 (6), 281-285.
9. Grant, W. B. (2002) An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 94, 1867-1875.
10. McKenna, M. J. (1992) Differences in vitamin D status between countries in young adults and the elderly. Am. J. Med. 93, 69-77.
11. Rochon P.A., J. H. Gurwitz, K. Sykora, M. Mandari, D. C. Streiner, S. Garfinkel, S.-L. T. Normand and G. M. Anderson. (2005) Reader's guide to critical appraisal of cohort studies: 1. Role and design. Br. Med. J. 330, 895-897.
12. Berwick, M. and Y.T. Chen. (1995) Reliability of reported sunburn history in a case-control study of cutaneous malignant melanoma. Am. J. Epidemiol. 141, 1033-1037.
13. English, D. R., B. K. Armstrong and A. Kricker. (1998) Reproducibility of reported measurements of sun exposure in a case-control study. Cancer Epidemiol. Biomarkers Prev. 7, 857-863.
14. Westerdahl, J., H. Anderson, H. Olsson and C. Ingvar. (1996) Reproducibility of a self-administered questionnaire for assessment of melanoma risk Int. J. Epidemiol. 25, 245-251.
15. Lips, P., M. C. Chapuy, B. Dawson-Hughes, H. A. Pols and M. F. Holick. (1999) An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos. Int. 9, 394-397.
16. Vieth, R. (2004) Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adults. J. Steroid Biochem. Mol. Biol. 89-90, 575-579.
17. Nowson, C. A. and C. Margerison. (2002) Vitamin D intake and vitamin D status of Australians. Med. J. Aust. 177, 149-152.
18. Thomas, M. K., D. M. Lloyd-Jones, R. I. Thadhani, A. C. Shaw, D. J. Deraska, B. T. Kitch, E. C. Vamvakas, I. M. Dick, R. L. Prince and J.S. Finkelstein. (1998) Hypovitaminosis D in medical inpatients. N. Engl. J. Med. 338, 777-783.
19. Dawson-Hughes B., G. E. Dallal, E. A. Krall, S. Harris, L. J. Sokoll and G. Falconer. (1991) Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Ann. Intern. Med. 115 (7), 505-512.
20. Kipen E, R. D. Helme, J. D. Wark and L. Flicker. (1995) Bone density, vitamin D nutrition, and parathyroid hormone levels in women with dementia. J. Am. Geriatr. Soc. 43, 1088-1091.
21. Sollitto, R. B., K. H. Kraemer and J. J. DiGiovanna. (1997) Normal vitamin D levels can be maintained despite rigorous photoprotection: six years' experience with xeroderma pigmentosum. J. Am. Acad. Dermatol. 37, 942-947.
22. Heaney R. P. (2004) Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am. J. Clin. Nutr. 80, 1706S-1709S.
23. Querings K. and J. Reichrath. (2004) A plea for the analysis of vitamin D levels in patients under photoprotection, including patients with Xeroderma pigmentosum (XP) and basal cell nevus syndrome (BCNS). Letter to the editor. Cancer Causes Control 15, 219.
24. Weinstock, M. A., M. J. Stampfer, R. A. Lew, W. C. Willett and A. J. Sober (1992) Case-control study of melanoma and dietary vitamin D: implications for advocacy of sun protection and sunscreen use. J. Invest. Dermatol. 98, 809-811.
25. Marks, R., P. A. Foley, D. Jolley, K. R. Knight, J. Harrison and S. C. Thompson. (1995) The effect of regular sunscreen use on vitamin D levels in an Australian population. Results of a randomized controlled trial. Arch. Dermatol. 131, 415-421.
26. Millen, A. E., M. A. Tucker, P. Hartge, A. Halpern, D. E. Elder, D. T. Guerry, E. A. Holly, R. W. Sagebiel and N. Potischman. (2004) Diet and melanoma in a case-control study. Cancer Epidemiol. Biomarkers Prev. 13, 1042-1051.
27. Slattery, M. L., M. Murtaugh, B. Caan, K. N. Ma, R. Wolff and W. Samowitz. (2004) Associations between BMI, energy intake, energy expenditure, VDR genotype and colon and rectal cancers (United States). Cancer Causes Control 15, 863-872.
28. Wong, H. L., A. Seow, K. Arakawa, H. P. Lee, M. C. Yu and S. A. Ingles. (2003) Vitamin D receptor start codon polymorphism and colorectal cancer risk: effect modification by dietary calcium and fat in Singapore Chinese. Carcinogenesis 24, 1091-1095.
29. Boyapati, S. M., R. M. Bostick, K. A. McGlynn, M. F. Fina, W. M. Roufail, K. R. Geisinger, M. Wargovich, A. Coker and J. R. Hebert. (2003) Calcium, vitamin D, and risk for colorectal adenoma: dependency on vitamin D receptor BsmI polymorphism and non-steroidal anti-inflammatory drug use? Cancer Epidemiol. Biomarkers Prev. 12, 631-637.
30. Grau, M. V., J. A. Baron, R. S. Sandler, R. W. Haile, M. L. Beach, T. R. Church and D. Heber. (2003) Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J. Natl. Cancer Inst. 95, 1765-1771.
31. Hutchinson, P. E., J. E. Osborne, J. T. Lear, A. G. Smith, P. W. Bowers, P. N. Morris, P. W. Jones, C. York, R. C. Strange and A. A. Fryer. (2000) Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. Clin. Cancer Res. 6, 498-504
32. Xu, Y., A. Shibata, J. E. McNeal, T. A. Stamey, D. Feldman and D. M. Peehl. (2003) Vitamin D receptor start codon polymorphism (FokI) and prostate cancer progression. Cancer Epidemiol. Biomarkers Prev. 12, 23-27.
33. Oakley-Girvan, I., Feldman, D., Eccleshall, T. R., Gallagher, R. P., Wu, A. H., Kolonel, L. N., Halpern, J., Balise, R. R., West, D. W., Paffenbarger, R. S., Jr. and A. S. Whittemore. (2004) Risk of early-onset prostate cancer in relation to germ line polymorphisms of the vitamin D receptor. Cancer Epidemiol. Biomarkers Prev. 13, 1325-1330.
34. Suzuki, K., H. Matsui, N. Ohtake, S. Nakata, T. Takei, H. Koike, H. Nakazato, H. Okugi, M. Hasumi, Y. Fukabori, K. Kurokawa and H. Yamanaka. (2003) Vitamin D receptor gene polymorphism in familial prostate cancer in a Japanese population. Int. J. Urol. 10, 261-266.
35. Cheteri M. B., J. L. Stanford, D. M. Friedrichsen, M. A. Peters, L. Iwasaki, M. C. Langlois, Z. Feng and E. A. Ostrander. (2004) Vitamin D receptor gene polymorphisms and prostate cancer risk. Prostate 59 (4), 409-418.
36. Habuchi, T., T. Suzuki, R. Sasaki, L. Wang, K, Sato, S. Satoh, T. Akao, N. Tsuchiya, N. Shimoda, Y. Wada, A. Koizumi, J. Chihara, O. Ogawa and T. Kato (2000) Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population. Cancer Res. 60, 305-308.
37. Correa-Cerro, L., P. Berthon, J. Haussler, S. Bochum, E. Drelon, P. Mangin, G. Fournier, T. Paiss, O. Cussenot and W. Vogel. (1999) Vitamin D receptor polymorphisms as markers in prostate cancer. Hum Genet 105, 281-7.
38. Chokkalingam A. P., K. A. McGlynn, Y. T. Gao, M. Pollack, J. Deng, I. A. Sesterhenn, F. K. Mostofi, J. F. Fraumeni and A.W. Hsing. (2001) Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: A population-based case-control study in China. Cancer Res. 61, 4333-4336.
39. Resnik, D. (2005) Is the Precautionary Principle Unscientific? Stud. Hist. Philos. Biol. Biomed. Sci. 34C, 329-344.
40. Glerup, H., K. Mikkelsen, L. Poulsen, E. Hass, S. Overbeck, J. Thomsen, P. Charles and E.F. Eriksen. (2000) Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited. J. Intern. Med. 247, 260-268.
41. Tangpricha, V., E. N. Pearce, T. C. Chen and M. F. Holick. (2002) Vitamin D insufficiency among free-living healthy young adults. Am. J. Med. 112, 659-662.
42. Brot, C., P. Vestergaard, N. Kolthoff, J. Gram, A. P. Hermann and O. H. Sorensen. (2001) Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone. Br. J. Nutr. 86 (Suppl. 1), S97-S103.
43. Liu, B. A., M. Gordon, J. M. Labranche, T. M. Murray, R. Vieth and N. H. Shear (1997) Seasonal prevalence of vitamin D deficiency in institutionalized older adults. J. Am. Geriatr. Soc. 45, 598-603.
44. Meyer, H. E., J. A. Falch, A. J. Sogaard and E. Haug (2004) Vitamin D deficiency and secondary hyperparathyroidism and the association with bone mineral density in persons with Pakistani and Norwegian background living in Oslo, Norway, The Oslo Health Study. Bone 35, 412-417.
45. Lawson, M., M. Thomas and A. Hardiman (1999) Dietary and lifestyle factors affecting plasma vitamin D levels in Asian children living in England. Eur. J. Clin. Nutr. 53, 268-272.
46. Fears, T. R., C. C. Bird, D. Guerry, R. W. Sagebiel, M. H. Gail, D. E. Elder, A. Halpern, E. A. Holly, P. Hartge and M. A. Tucker. (2002) Average midrange ultraviolet radiation flux and time outdoors predict melanoma risk. Cancer Res. 62, 3992-3996.
47. Rosso, S., F. Joris and R. Zanetti. (1999) Risk of basal and squamous cell carcinomas of the skin in Sion, Switzerland: a case-control study. Tumori 85, 435-442.
48. Rosso, S., R. Zanetti, C. Martinez, M. J. Tormo, S. Schraub, H. Sancho-Garnier, S. Franceschi, L. Gafa, E. Perea, C. Navarro, R. Laurent, C. Schrameck, R. Talamini, R. Tumino and J. Wechsler. (1996) The multicentre south European study 'Helios'. II: Different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin. Br. J. Cancer 73, 1447-1454.
49. Rosso, S., R. Zanetti, M. Pippione and H. Sancho-Garnier. (1998) Parallel risk assessment of melanoma and basal cell carcinoma: skin characteristics and sun exposure. Melanoma Res. 8, 573-583.
50. Kricker, A., B. K. Armstrong, D. R. English and P. J. Heenan. (1995) A dose-response curve for sun exposure and basal cell carcinoma. Int. J. Cancer 60, 482-488.
51. Espinosa Arranz, J., J. J. Sanchez Hernandez, P. Bravo Fernandez, M. Gonzalez-Baron, P. Zamora Aunon, E. Espinosa Arranz, J. I. Jalon Lopez and A. Ordonez Gallego. (1999) Cutaneous malignant melanoma and sun exposure in Spain. Melanoma Res. 9, 199-205.
52. Green, A. C. and M.G. O'Rourke. (1985) Cutaneous malignant melanoma in association with other skin cancers. J. Natl. Cancer Inst. 74, 977-980.
53. Holman, C. D. and B.K. Armstrong. (1984) Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types. J. Natl. Cancer Inst. 73, 75-82.
54. Veierod MB, E., Weiderpass M. Thorn, J. Hansson, E. Lund, B. K. Armstrong and H.-O. Adami (2003) A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women. J. Natl. Cancer Inst. 95, 1530-1538.
55. Armstrong, B. K. (1988) Epidemiology of malignant melanoma: intermittent or total accumulated exposure to the sun? J. Dermatol. Surg. Oncol. 14, 835-849.
56. Kricker, A., B. K. Armstrong and D. R. English (1994) Sun exposure and non-melanocytic skin cancer. Cancer Causes Control 5, 367-392.
57. Holick, M.F. (2004) Vitaim D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am. J. Clin. Nutr. 79, 362-371.
58. Holick, M.F. (2003) Vitamin D: a millenium perspective. J. Cell. Biochem. 88, 296-307.
59. Holick, M.F., E. S. Siris, N. Binkley, M. K. Beard, A. Khan, J. T. Katzer, R. A. Petruschke, E. Chen and A. E. de Papp. (2005) Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J. Clin. Endocrinol. Metab. 90, 3215-3224.
60. Aris, R.M., P.A Merkel, L. K. Bachrach, D. S. Borowitz, M. P. Boyle, S. L. Elkin, T. A. Guise, D. S. Hardin, C. S. Hawaorth, M. F. Holick, P. M. Joseph, K. O'Brien, E. Tullis, N. B. Watts and T. B. White. (2005). Consensus Statement: Guide to bone health and disease in cystic fibrosis. J. Clin. Endocrinol. Metab. 90, 188-189.
61. Fairfield, K. M. and R. H. Fletcher. (2002) Vitamins for chronic disease prevention in adults: scientific review. JAMA. 287 (23), 3116-3126.
62. Holick, M. (2001) Sunlight "D"ilemma: risk of skin cancer or bone disease and muscle weakness. The Lancet 357, 4-6.
63. Heaney, R.P., K.M. Davies, T. C. Chen, M. F. Holick and M.J. Barger-Lux (2003) Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am. J. Clin. Nutr. 77 (1), 204-210.
64. Moore, C., M. M. Murphy, D. R. Keast and M.F. Holick (2004) Vitamin D intake in the United States. J. Am. Diet. Assoc. Online 104, 6.
65. Dawson-Hughes, B., R. P. Heaney, M. F. Holick, P. Lips, P. J. Meunier and R. Vieth. (2005) Estimates of optimal vitamin D status. Editorial. Osteoporosis Int. 16, 713-716.